Activation of TIMP-2/progelatinase A complex by stromelysin. 1992

K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
Division of Cell Biology, Kihara Institute for Biological Research, Yokohama City University, Japan.

Progelatinase A was purified as a complex with TIMP-2 from the conditioned medium of a human glioblastoma cell line. The TIMP-2/progelatinase complex was resistant to the activation by p-aminophenylmercuric acetic acid (APMA), and showed less than 10% of the activity of the TIMP-2-free active enzyme. When the complex was incubated with stromelysin in the presence of APMA, the 64-kDa progelatinase was effectively converted to the 57-kDa mature enzyme, increasing its gelatinolytic activity about 8-fold. These results suggest that stromelysin is a natural activator of TIMP-2-bound progelatinase A.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010434 Pepsin A Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice. Pepsin,Pepsin 1,Pepsin 3
D010662 Phenylmercuric Acetate A phenyl mercury compound used mainly as a fungicide. Has also been used as a herbicide, slimicide, and bacteriocide. Acetoxyphenylmercury,Falisan-Nassbeize,Verdasan,Acetate, Phenylmercuric,Falisan Nassbeize,FalisanNassbeize
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations

Related Publications

K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
February 1997, Biological chemistry,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
September 1994, Annals of the New York Academy of Sciences,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
June 1998, The Journal of biological chemistry,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
June 1995, The Biochemical journal,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
November 1996, FEBS letters,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
October 1994, Biochimica et biophysica acta,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
June 1991, European journal of biochemistry,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
July 1996, The Journal of biological chemistry,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
June 2003, The Biochemical journal,
K Miyazaki, and F Umenishi, and K Funahashi, and N Koshikawa, and H Yasumitsu, and M Umeda
June 1995, Cancer research,
Copied contents to your clipboard!